Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5896 to 5910 of 7708 results

  1. The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

    Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

  2. Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics that affect life expectancy and to develop algorithms and prediction tools for patients and healthcare providers to predict reduced life expectancy?

    Recommendation ID NG56/4 Question Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics

  3. The committee recommended further research on the incidence and effect of post-contrast acute kidney injury (PC‑AKI) in people with eGFR less than 30 ml/min/1.73 m2.

    Recommendation ID DG37/1 Question The committee recommended further research on the incidence and effect of post-contrast acute kidney

  4. Prediction tools: What is the effectiveness of prediction tools for identifying women who are at risk of pelvic floor dysfunction?

    Recommendation ID NG210/05 Question Prediction tools: What is the effectiveness of prediction tools for identifying women who are at risk

  5. Polysomnography:- Does preoperative screening of people who are at risk of obstructive sleep apnoea with polysomnography identify those at higher risk of postoperative complications?

    Recommendation ID NG45/1 Question Polysomnography:- Does preoperative screening of people who are at risk of obstructive sleep apnoea with

  6. Polysomnography:- Does treating obstructive sleep apnoea perioperatively improve outcomes?

    Recommendation ID NG45/2 Question Polysomnography:- Does treating obstructive sleep apnoea perioperatively improve outcomes? Any

  7. Are digital and mobile health behaviour change interventions as effective as face-to-face, standard care, or combination approaches for some populations?

    Recommendation ID NG183/4 Question Are digital and mobile health behaviour change interventions as effective as face-to-face, standard

  8. Probiotic and prebiotic supplements:- What is the clinical and cost effectiveness of probiotics or prebiotics to treat NAFLD in adults, young people and children?

    Recommendation ID NG49/4 Question Probiotic and prebiotic supplements:- What is the clinical and cost effectiveness of probiotics or prebiotics

  9. What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic markers of developing post‑COVID‑19 syndrome?

    Recommendation ID NG188/3 Question What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic

  10. Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor of survival in people with MND under NHS care in England and/or Wales?

    Recommendation ID NG42/3 Question Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor

  11. Promoting a shift to zero- and low-emission travel:- What methods are effective and cost effective at promoting a shift to zero- and low-emission modes of travel, including active travel?

    Recommendation ID NG70/2 Question Promoting a shift to zero- and low-emission travel:- What methods are effective and cost effective at

  12. Promoting health and wellbeing:- What is the most effective method for delivering health promotion activities and who should lead them (peers or professionals)?

    Recommendation ID NG57/3 Question Promoting health and wellbeing:- What is the most effective method for delivering health promotion activities

  13. Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most likely to benefit from prophylactic antibiotics?

    Recommendation ID NG115/5 Question Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who